After Medtronic lobbying push, the FDA had change of heart.
Anna Wilde
AW
Mathews
Thomas M
TM
Burton
D001014:Aortic Aneurysm / Q000601:surgery; D004864:Equipment and Supplies / Q000009:adverse effects; D007221:Industry; D033181:Information Dissemination / Q000941:ethics; D008119:Lobbying; D017594:Publication Bias; D012180:Retraction of Publication as Topic; D012449:Safety; D015607:Stents / Q000009:adverse effects; D014481:United States; D014486:United States Food and Drug Administration